A San Francisco-based immunology company announced new preclinical research highlighting novel mechanisms by which SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) enters host cells and identifying how auxiliary receptors may impact the clinical efficacy of monoclonal antibodies (mAbs).
Considerable Neurologic, Psychiatric Morbidity Reported After COVID-19
Estimated incidence of neurological or psychiatric diagnosis was 33.62 percent among 236,379 patients
March 2020 to January 2021 Saw 23 Percent Jump in Mortality
Death rate was higher among non-Hispanic Blacks; 72.4 percent of excess deaths were attributed to COVID-19
Oral COVID-19 Vaccine Being Tested
T cell oral vaccine targets the globe in the middle of the virus, a part less prone to mutation
NIH Starts Trial Looking at Rare Allergic Reactions to COVID-19 Vaccines
Research will also address biological mechanism causing the reactions and whether there is a way to predict risk
Special ACA Enrollment Window Brings Insurance to 500,000 Americans
Consumers who were already enrolled at the beginning of this year are also entitled to the increased financial aid
Poll: Despite Pandemic’s Toll, Many Older Adults Do Not Have Living Wills
Only 7 percent of respondents said COVID-19 had motivated them to have a conversation with loved ones about their wishes if they became severely ill
COVID-19 Cases Climb in the Midwest as British Variant Takes Hold in U.S.
Officials warn of fourth wave of COVID-19 cases this spring due to emergence of more contagious variants. easing of social distancing